Russian COVID-19 vaccine shows 91.6% efficacy in phase 3 trial

Russia's Sputnik V vaccine is 91.6% effective against symptomatic Covid-19, interim trial results suggest

Why COVID Vaccines Are Likely Safe for Pregnant People

UBC study highlights the best style and fabrics for COVID-19 face masks